Pn Ivf Access Private Limited - Due diligence report

A 360° intelligence report on Ivf Access: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…

2020-03-18 Bengaluru, Karnataka Active Unlisted Active Compliant
PI Pn Ivf Access Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ivf Access — 360° Intelligence Report

Generated from MCA filings & public records
74/100
Trust Score
Moderate

Ivf Access is assessed as Moderate with a Trust Score of 74/100. Ivf Access is an active private limited foreign company incorporated in india incorporated in 2020, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 21 Jul 2026 from the latest processed filings. Pn Ivf Access Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
90/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 90/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 2 auditor resignation(s) filed - latest: RPAR AND CO LLP on 2023-11-21.
  • 3 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
NARESH NAGESH RAO 01234567 Director 01/04/2018 6 yrs Approved
KANIKA MAYAR 01234567 Director 01/04/2018 6 yrs Approved
NIKHIL RAJMOHAN 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • NIKHIL RAJMOHAN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Pn Ivf Access Pte Limited
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Pn Ivf Access Pte Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +38% over 2 year(s).
Latest year revenue grew 1.42.
EPFO headcount growing - hiring signal.
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
2 auditor resignation(s) on record - review the stated reasons.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment63/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 13 events
05 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
20 Dec 2022
Securities allotted
200001 Equity Shares - 3.78 cr raised
01 Nov 2021
Securities allotted
134000 Equity Shares - 10.05 cr raised
01 Sep 2021
Director appointed
KANIKA MAYAR (Nominee Director)
Director ceased
NARESH NAGESH RAO
Director ceased
KANIKA MAYAR
Director ceased
NIKHIL RAJMOHAN
28 Feb 2021
Director ceased
SETHURAMAN PRAVIN KUMAR
22 Feb 2021
Director appointed
NARESH NAGESH RAO (Director)
04 Jun 2020
Securities allotted
199980 Equity Shares - 15.00 cr raised
25 May 2020
Director appointed
NIKHIL RAJMOHAN (Director)
18 Mar 2020
Incorporated
Registered with Roc Bangalore
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 2 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); review board churn before relying on management continuity.
3 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Virom Healthcare Private Limited U85300MP2019PTC048884 Indore, Madhya Pradesh, India
Hitech Dentics Private Limited U85120WB2003PTC096827 Kolkata, West Bengal, India
Chiranjeev Multispeciality Hospital Private Limited U85100UP2020PTC129015 Jhansi, Uttar Pradesh, India
Arcofemi Healthcare Private Limited U24240DL2011PTC216307 New Delhi, Delhi, India
Vama Womens Hospital Private Limited U85300GJ2019PTC108045 Surat, Gujarat, India
Ahmednagar Cathlab (India) Private Limited U85110PN2002PTC017364 Ahmednagar, Maharashtra, India
Paramitha Diagnostics And Healthcare U85300TG2021PTC152427 Hyderabad, Telangana, India
Medcords U74999RJ2016PTC055981 Kota, Rajasthan, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ivf Access before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ivf Access: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Ivf Access - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Ivf Access pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Ivf Access - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ivf Access an active company?

Ivf Access has MCA status “Active” with a compliance score of 90/100 (Low Risk).

Is Ivf Access financially healthy?

Ivf Access has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Ivf Access?

Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ivf Access?

The ultimate holding entity is Pn Ivf Access Pte Limited. 3 active director(s) are on record.

Does Ivf Access have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Ivf Access up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 90/100 (Low Risk).

Is it risky to lend to Ivf Access?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.